Top News: #Infusiontherapy

Here are the top read news for #infusiontherapy:


Taking Central Line Infection Prevention to the Next Level:

Central venous catheters (CVCs) play an integral role in healthcare, however studies have shown that they are among the most frequent cause of healthcare-associated infections (HAIs). Their use is associated with a risk of bloodstream infection caused by microorganisms colonizing the external surface of the device or the fluid pathway when the device is inserted or in the course of its use. The Joint Commission’s CLABSI Toolkit notes that “Employing relatively simple evidence-based practices to reduce, if not eliminate, CLABSIs appears to be within the reach of even resource-limited settings. Within this framework, HAIs—and CLABSIs in particular—are more and more being viewed as ‘preventable’ events.” Read more

centrallineinfectionDo no harm -There’s an infection hospitals can nearly always prevent. Why don’t they?

Nora had blonde, curly hair and a big laugh, and seemed to hate wearing pants — pictures of her as a toddler show her wiggling right out of them. Nora was also born prematurely with underdeveloped lungs. A few months before her third birthday, she underwent a small surgical procedure that placed a thin, snakelike tube running through her chest to her heart. Doctors used it to pump medicine into her bloodstream that would help her lungs grow. Read more


What Is Chemotherapy? The Ins And Outs Of Treatment, And How It Affects Cancer Patients:

Chemotherapy dates back to World War II when, according to the American Cancer Society(ACS), the U.S. Army was studying a compound called nitrogen mustard. When this compound effectively worked against cancers, such as lymphoma and acute leukemia, researchers focused on discovering “drugs that block different functions in cell growth and replication.” Thus, chemotherapy was born. Read more

X-ray photoemission spectroscopyGraphene coating on catheters may improve chemo effectiveness:

emotherapy is a type of cancer treatment that uses powerful chemicals to destroy cancer cells. It is usually delivered directly into the patient’s veins using a catheter. To prevent bacterial infection, the catheter, and the equipment it is attached to, is usually coated with silver. Read more


Continuation of gefitinib after progression on first-line gefitinib did not improve PFS in patients with EGFR-mutation-positive NSCLC who received platinum-double based chemo as subsequent line of trePlatinum-Based Doublet Chemo Remains Standard of Care after First-Line Gefitinib:

Continuation of gefitinib after radiological disease progression on first-line gefitinib did not improve progression-free survival in patients with EGFR-mutation-positive non-small cell lung cancer (NSCLC) who received platinum-double based chemotherapy as subsequent line of treatment, a new study published in the journal The Lancet Oncology has shown. Read more